TY  - JOUR
T1  - TReatment with clopidogrel after myocardial infarction
AU  - Lin G, Li Y, Han C
Y1  - 2012/12/19
N1  - 10.1001/jama.2012.28718
JO  - JAMA
SP  - 2456
EP  - 2457
VL  - 308
IS  - 23
N2  - 
In a meta-analysis by Berger and colleagues,2 the risk reduction with clopidogrel in women was greatest for MI (odds ratio [OR], 0.81; 95% CI, 0.70-0.93) and not statistically significant for stroke (OR, 0.91; 95% CI, 0.69-1.21) or total death (OR, 0.99; 95% CI, 0.90-1.08). In contrast, the risk reduction with clopidogrel in men was not only significant for MI (OR, 0.83; 95% CI, 0.76-0.92), but also for stroke (OR, 0.83; 95% CI, 0.71-0.96) and total death (OR, 0.91; 95% CI, 0.84-0.97).2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.28718
UR  - http://dx.doi.org/10.1001/jama.2012.28718
ER  -